Viatris (VTRS) Other Non Operating Income (2019 - 2026)
Viatris (VTRS) posted quarterly Other Non Operating Income of -$47.5 million for Q1 2026, up 52.17% year-over-year from -$31.2 million in Q1 2025, and down 54.72% quarter-over-quarter from -$30.7 million in Q4 2025.
Viatris (VTRS) Other Non Operating Income (2019 - 2026) Analysis & Trends
Viatris' Other Non Operating Income history runs 8 years deep, the most recent figure standing at -$47.5 million for Q1 2026.
- In Q1 2026, Other Non Operating Income rose 52.17% year-over-year to -$47.5 million; the TTM figure through Mar 2026 stood at -$478.8 million (down 421.57% YoY), while the FY2025 annual figure was -$530.6 million, down 536.97% from the prior year.
- Other Non Operating Income for Q1 2026 stood at -$47.5 million, down from -$30.7 million in the prior quarter.
- The five-year high for Other Non Operating Income was $1.8 billion in Q4 2022, with the low at -$333.5 million in Q2 2025.
- The 5-year median for Other Non Operating Income is -$6.1 million (2024), against an average of $80.5 million.
- The sharpest annual moves came in 2022 and 2025: Other Non Operating Income surged 8198.17% in 2022, then plunged 5367.21% in 2025.
- Viatris' Other Non Operating Income stood at $1.8 billion in 2022, then slumped by 114.28% to -$259.6 million in 2023, then jumped by 101.31% to $3.4 million in 2024, then plunged by 1002.94% to -$30.7 million in 2025, then sank by 54.72% to -$47.5 million in 2026.
- Business Quant data shows VTRS's Other Non Operating Income at -$47.5 million in Q1 2026, -$30.7 million in Q4 2025, and -$67.1 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.76 Bn | 42.80 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.05 Bn | 39.39 Bn | 2.15 Bn |
| 3 | Zoetis | 31.51 Bn | 29.84 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.70 Bn | 22.90 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.27 Bn | 19.61 Bn | 683.80 Mn |
| 6 | Viatris | 18.83 Bn | 17.95 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.65 Bn | 15.26 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 12.06 Bn | 11.53 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.95 Bn | - |
| 10 | Alkermes | 8.27 Bn | 7.61 Bn | 397.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 50.40 Mn |
| Mar 31, 2026 | -47.50 Mn |
| Dec 31, 2025 | -30.70 Mn |
| Sep 30, 2025 | -67.10 Mn |
| Jun 30, 2025 | -333.50 Mn |
| Mar 31, 2025 | -99.30 Mn |
| Dec 31, 2024 | 3.40 Mn |
| Sep 30, 2024 | 10.20 Mn |
| Jun 30, 2024 | -6.10 Mn |
| Mar 31, 2024 | 139.10 Mn |
| Dec 31, 2023 | -259.60 Mn |
| Sep 30, 2023 | 92.00 Mn |
| Jun 30, 2023 | 107.50 Mn |
| Mar 31, 2023 | 69.90 Mn |
| Dec 31, 2022 | 1.82 Bn |
| Sep 30, 2022 | 20.60 Mn |
| Jun 30, 2022 | -13.50 Mn |
| Mar 31, 2022 | -33.70 Mn |
| Dec 31, 2021 | 21.90 Mn |
| Sep 30, 2021 | -5.80 Mn |